- Cytodyn Inc Company Update Call TranscriptDec 14, 2023
- Cytodyn Inc Annual Shareholders Meeting TranscriptNov 09, 2023
- Cytodyn Inc Investment Community Webcast TranscriptJul 24, 2023
- Cytodyn Inc To Provide a Company Update TranscriptApr 11, 2023
- Cytodyn Inc Investment Community Webcast TranscriptDec 29, 2022
- Cytodyn Inc To Host R&D Update-Virtual TranscriptDec 07, 2022
- Cytodyn Inc Investment Community Webcast TranscriptOct 31, 2022
- Cytodyn Inc Investment Community Webcast TranscriptSep 28, 2022
- Cytodyn Inc Investment Community Webcast TranscriptMar 31, 2022
- Cytodyn Inc Investment Community Webcast TranscriptMar 08, 2021
- Cytodyn Inc with Dr.Pourhassan gives an update on CytoDyn's COVID-19 path and more on Proactive TranscriptOct 24, 2020
- Cytodyn Inc Investor Call TranscriptSep 02, 2020
- Cytodyn Inc To Host Investment Community Conference Call TranscriptAug 12, 2020
- Cytodyn Inc Dr. Nader Pourhassan, CytoDyn's CEO, Addresses The False Claims Made By STAT News TranscriptJul 31, 2020
- Cytodyn Inc Special Meeting TranscriptJul 29, 2020
- Cytodyn Inc InvestTalk TranscriptJul 24, 2020
- Cytodyn Inc Dr. Pourhassan Discusses Citron Research's False Report TranscriptJul 02, 2020
- Cytodyn Inc Developing New Therapies for Treatment of Human Immunodeficiency Virus TranscriptJun 18, 2020
- Cytodyn Inc To Host Investment Community Conference Call TranscriptJun 13, 2020
- Cytodyn Inc To Host Investor Community Conference Call TranscriptJun 11, 2020
- Cytodyn Inc Discussion on Company's Trials and COVID19 on Crush the Street Call TranscriptJun 07, 2020
- Cytodyn Inc at CytoDyn (OTC: CYDY) June 2 2020 - Livestream TranscriptJun 02, 2020
- Cytodyn Inc Investor Community Conference Call TranscriptMay 26, 2020
- Cytodyn Inc CytoDyn on Wall Street Reporter with Drs. Pourhassan, Lalezari, and Patterson TranscriptMay 21, 2020
- Cytodyn Inc at Lee Kelso discusses Leronlimab on WOWO radio TranscriptMay 20, 2020
- Cytodyn Inc Shares Manuscript Of Potential Coronavirus Treatment TranscriptMay 07, 2020
- Cytodyn Inc Leronlimab For COVID-19 Coronavirus Treatment TranscriptMay 02, 2020
- Cytodyn Inc Wall Street Reporter TranscriptMay 01, 2020
- Cytodyn Inc At This Drug is Now a Leading Contender to Treat COVID-19 TranscriptApr 27, 2020
- Cytodyn Inc COVID-19 Coronavirus Treatment Clinical Data Update TranscriptApr 18, 2020
- Cytodyn Inc Plans on Moving Forward With COVID-19 Trial TranscriptApr 13, 2020
- Cytodyn Inc at CytoDyn (OTC: CYDY) Coronaovirus Treatment gets FDA EMERGENCY IND + update on HIV & Cancer pipeline TranscriptMar 02, 2020
- Cytodyn Inc at This Week on RedChip TV: 3 Stocks Positioned for Upside in 2020 TranscriptFeb 19, 2020
- Cytodyn Inc at Cytodyn Inc Next Super Stock Live Hosted by Wall Street Reporter TranscriptFeb 11, 2020
- Cytodyn Inc Discusses New HIV Drug and Plans for Commercialization, Addressing $2 Billion Market Call TranscriptFeb 10, 2020
- Cytodyn Inc at Cytodyn Inc Next Super Stock Live Hosted by Wall Street Reporter TranscriptJan 23, 2020
Cytodyn Inc COVID-19 Coronavirus Treatment Clinical Data Update Transcript
Good afternoon, everybody, and welcome to Wall Street Reporter's next Super Stock live stream for today, April 17, 2020. We're very proud to bring you a very special presentation from CytoDyn titled on as many of you have been following since August, the stock has done tremendously, the company has reported incredible progress.
And obviously, there's a very topical a presentation for today. As you know, the stock is up significantly and with CytoDyn's impressive pipeline, this could be just the beginning. So today, we have a lot of people on the call. So I'm going to skip my usual remarks. We'll get right to it.
The format for today is simple. Nader Pourhassan, the CEO of CytoDyn is going to speak, then we're going to engage in a panel discussion with Dr. Bruce and Jay, and then we'll open up for Q&A. Hopefully, we'll have time to answer the questions.
We've got about 70 questions. I don't know if we'll have time, but with that being said everybody up, please welcome Dr. Pourhassan. Nader, take it away.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)